Search This Blog

Wednesday, July 8, 2026

Prime Medicine wins arbitration with Beam

 

Prime Medicine wins arbitration with Beam Therapeutics confirming PM647 is within licensed field with no monetary damages owed

  • Company reiterates plans to file an IND/CTA for its AATD program in Q3 2026.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)